The central nervous system accounts for only 2% of the whole body mass but
contains almost a quarter of the unesterified cholesterol present in the wh
ole individual. This sterol is largely present in two pools comprised of th
e cholesterol in the plasma membranes of glial cells and neurons and the ch
olesterol present in the specialized membranes of myelin. From 0.02% (human
) to 0.4% (mouse) of the cholesterol in these pools turns over each day so
that the absolute flux of sterol across the brain is only approximately 0.9
% as rapid as the turnover of cholesterol in the whole body of these respec
tive species. The input of cholesterol into the central nervous system come
s almost entirely from in situ synthesis, and there is currently little evi
dence for the net transfer of sterol from the plasma into the brain of the
fetus, newborn or adult. In the steady state in the adult, an equivalent am
ount of cholesterol must move out of the brain and this output is partly ac
counted for by the formation and excretion of 24S-hydroxycholesterol. This
cholesterol turnover across the brain is increased in neurodegenerative dis
orders such as Alzheimer's disease and Niemann-Pick type C disease, Indirec
t evidence suggests that large amounts of cholesterol also turn over among
the glial cells and neurons within the central nervous system during brain
growth and neuron repair and remodelling. This internal recycling of sterol
may involve ligands such as apolipoproteins E and Al, and one or more memb
rane transport proteins such as members of the low density lipoprotein rece
ptor family. Changes in cholesterol balance across the whole body may, in s
ome way, cause alterations in sterol recycling and apolipoprotein E express
ion within the central nervous system, which, in turn; may affect neuron an
d myelin integrity. Further elucidation of the processes controlling these
events is very important to understand a variety of neurodegenerative disor
ders. Curr Opin Lipidol 12:105-112. (C) 2001 Lippincott Williams & Wilkins.